glp 1 gout How GLP-1 Receptor Agonists Evolved from Diabetes to Weight Loss Treatments GLP-1 Gout Risk: Do These

GHRH Peptides Side-by-Side Feature Receptor Target Tesamorelin GHRH receptor Sermorelin GHRH receptor CJC-1295 (DAC) GHRH receptor Feature Peptide Length Tesamorelin 44 amino acids (modified) Sermorelin 29 amino acids CJC-1295 (DAC) 29 amino acids + DAC Feature Half-Life Tesamorelin 26-38 minutes Sermorelin 11-12 minutes CJC-1295 (DAC) ~6-8 days Feature Dosing Frequency Tesamorelin Once daily Sermorelin Once nightly CJC-1295 (DAC) 1-2x weekly Feature FDA Status Tesamorelin Approved (2010

Hepatology 45 , 12981305, (2007)

Summer Promo

Although treatment with each of the three compounds alone was also effective, the combination of chlorogenic acid (CA), neochlorogenic acid (NCA), and cryptochlorogenic acid (CCA) demonstrated the greatest effect on HCECs in the scratch wound-healing assay

Jones LL, et al